ArticleBioMed research international2026
Reference Range of Red Cell Distribution Width-to-Albumin Ratio in Healthy US Adults: A Cross-Sectional Study.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reference Range of Red Cell Distribution Width-to-Albumin Ratio in Healthy US Adults: A Cross-Sectional Study.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The red blood cell distribution width-to-albumin ratio (RAR) has been identified as a reliable prognostic marker for all-cause mortality and various diseases. However, the reference range for RAR across different sexes, age groups, and races remains unknown. This study was conducted to establish age-, sex-, and race-specific reference intervals for the RAR in the general US adult population. A cross-sectional analysis was performed using seven biennial cycles (2005-2018) of the National Health and Nutrition Examination Survey (NHANES), comprising 22,582 adults aged ≥ 18 years. Pregnant or lactating women and individuals with a history of diabetes mellitus, cardiovascular or cerebrovascular disease, liver disease, thyroid disease, kidney disease, or malignancy were excluded. Age-, sex-, and race-stratified reference intervals (2.5th-97.5th percentiles) for RAR were derived using survey-weighted methods. The weighted analysis represented more than 141 million US adults. The median RAR was 3.0 %dL/g (IQR: 2.8-3.2), with slightly higher values observed in women compared with men and a modest age-dependent increase observed. Non-Hispanic Black individuals were found to have marginally elevated RAR compared with other racial/ethnic groups, along with greater variability. The overall reference interval was determined to be 2.5-4.1 %dL/g. The widest interval was observed among non-Hispanic Black women aged < 65 years; the narrowest, among Hispanic and non-Hispanic White men in the same age group. In conclusion, RAR reference intervals showed minimal variation across demographic strata, supporting the potential utility of RAR as a robust biomarker for clinical and research applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.